{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:03:08Z","timestamp":1761807788393},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.lpm.2013.01.031","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T22:25:50Z","timestamp":1362522350000},"page":"527-530","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["L12. Rheumatoid arthritis vasculitis"],"prefix":"10.1016","volume":"42","author":[{"given":"Xavier","family":"Pu\u00e9chal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.01.031_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005792-198611000-00002","article-title":"Rheumatoid vasculitis: survival and associated risk factors","volume":"65","author":"Vollertsen","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0010","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients","volume":"38","author":"Puechal","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2013.01.031_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.1780390213","article-title":"The mortality of rheumatoid vasculitis compared with rheumatoid arthritis","volume":"39","author":"Voskuyl","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.lpm.2013.01.031_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","article-title":"Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases","volume":"60","author":"Scott","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2013.01.031_bib0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry","volume":"64","author":"Puechal","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/keh210","article-title":"Rheumatoid vasculitis: becoming extinct?","volume":"43","author":"Watts","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extra-articular rheumatoid arthritis in Olmsted County Minnesota, in 1995\u20132007 versus 1985\u20131994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2013.01.031_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","article-title":"Systemic rheumatoid vasculitis: a review","volume":"36","author":"Genta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2013.01.031_bib0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/rheumatology\/33.9.832","article-title":"The incidence of rheumatoid vasculitis in the Norwich Health Authority","volume":"33","author":"Watts","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2013.01.031_bib0060","series-title":"La vascularite rhumato\u00efde. Sany Polyarthrite rhumato\u00efde: aspects actuels et perspectives","author":"Bacon","year":"1987"},{"key":"10.1016\/j.lpm.2013.01.031_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(69)90238-1","article-title":"A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis","volume":"47","author":"Mongan","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2013.01.031_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02041550","article-title":"Rheumatoid vasculitis: diagnostic and therapeutic decisions","volume":"2","author":"Panush","year":"1983","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2013.01.031_bib0075","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0080","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","article-title":"Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity","volume":"62","author":"Carmona","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2013.01.031_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"3rd. Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2013.01.031_bib0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1529-0131(199904)42:4<824::AID-ANR32>3.0.CO;2-0","article-title":"Necrotizing vasculitis of the peripheral nervous system: nonsystemic or clinically undetectable?","volume":"42","author":"Puechal","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2013.01.031_bib0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10067-008-1054-2","article-title":"Necrotising scleritis and connective tissue disease--three cases and a review","volume":"28","author":"Nizam","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2013.01.031_bib0100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","article-title":"Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management","volume":"14","author":"Messmer","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.lpm.2013.01.031_bib0105","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1002\/art.20588","article-title":"Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis","volume":"50","author":"Gorman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2013.01.031_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2013.01.031_bib0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.30296","article-title":"Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides","volume":"63","author":"Le Guenno","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2013.01.031_bib0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","volume":"67","author":"Puechal","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2013.01.031_bib0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11926-010-0130-1","article-title":"Rheumatoid vasculitis: vanishing menace or target for new treatments?","volume":"12","author":"Bartels","year":"2010","journal-title":"Curr Rheumatol Rep"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T03:53:31Z","timestamp":1539834811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0755498213000808"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.01.031","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}